Skip to content

Pilot Testing for Midline Measuring Device

Pilot Testing for Midline Measuring Device

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04883060
Acronym
MMD
Enrollment
40
Registered
2021-05-12
Start date
2019-01-01
Completion date
2019-07-01
Last updated
2024-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ventriculo-Peritoneal Shunt Infection

Brief summary

Identifying the exact middling on the patient's head during the planning phase of surgery is crucial yet can be challenged by patient's head position and hair. The investigators have invented a device that uses anatomical landmark to quickly and gracefully identify the midline on a patient's head. The device is a U-shaped instrument equipped with a laser pointer at the midline. The instrument also has smooth spheres that can be positioned over the patients' ears bilaterally. The midline laser pointer will identify the midline on the patients' head. this measurement procedure is typically done after the patient is placed under anesthesia. The standard way of determining the midline on the skull is simply by surgeon's vision without any measurements. This new technique will be contrasted against the standard way. The device was invented by investigators in neurosurgery (led by Dr. Matthew Howard III). This is not patented it at this time. There is no company involved in manufacturing (assembly was completed with the help of the hospital's machine shop).

Interventions

DEVICEmidline localizer

a midline localizer device with a laser pointer is used to localize where the midline is likely to be located on the patient head prior to the surgery.

Sponsors

University of Iowa
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Patients with normal pressure hydrocephalus who are scheduled to undergo a ventriculoperitoneal shunt surgery

Exclusion criteria

* Patients who are not able to consent

Design outcomes

Primary

MeasureTime frameDescription
Midline LocalizationImmediate postop, an average of 4 hoursThe average distance separating the staple from the lateral edge of the sagittal sinus

Secondary

MeasureTime frameDescription
Burr Hole PlacementImmediately Post-op, an average of 4 hoursNumber of participants in which their Burr hole placement was between 3 and 4 cm away from anatomical midline

Countries

United States

Participant flow

Participants by arm

ArmCount
Intervention
Patients undergoing ventriculoperitoneal surgery where the midline localizer was used midline localizer: a midline localizer device with a laser pointer is used to localize where the midline is likely to be located on the patient head prior to the surgery.
40
Total40

Baseline characteristics

CharacteristicIntervention
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
24 Participants
Age, Categorical
Between 18 and 65 years
16 Participants
Race and Ethnicity Not Collected— Participants
Region of Enrollment
United States
40 Participants
Sex: Female, Male
Female
26 Participants
Sex: Female, Male
Male
14 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 40
other
Total, other adverse events
4 / 40
serious
Total, serious adverse events
0 / 40

Outcome results

Primary

Midline Localization

The average distance separating the staple from the lateral edge of the sagittal sinus

Time frame: Immediate postop, an average of 4 hours

ArmMeasureValue (MEAN)Dispersion
InterventionMidline Localization0.9 mmStandard Deviation 1.6
Secondary

Burr Hole Placement

Number of participants in which their Burr hole placement was between 3 and 4 cm away from anatomical midline

Time frame: Immediately Post-op, an average of 4 hours

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
InterventionBurr Hole Placement37 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026